Accenture has won a three-year contract to develop a new system for evaluating medicines for a national agency in Italy, the company announced Tuesday.
The company will work with the Italian Medicines Agency, which approves all new medicines in the country, to build and maintain the system and also provide the agency management consulting services.
Gianmario Pisanu, head of Accenture’s health and public service business in Italy, said in a release the company wants to help the agency provide citizens access to treatment and also promote research and development.
Accenture brings experience in developing central and local health administrative processes for public sector customers worldwide, Pisanu added.
According to the company, the AIFA’s stakeholders include patients, civil society, institutions and pharmaceutical companies.
The company recently purchased Octagon, a Pennsylvania-based clinical and regulatory information management solutions provider, with intention to expand in the clinical services market.
One Response to "Accenture to Develop Italy Medicine Evaluation IT System; Gianmario Pisanu Comments"